Skip to main content
. 2021 Oct 26;27:10760296211035446. doi: 10.1177/10760296211035446

Table 2.

Clinical Data of ACI Patients and Healthy Controls.

ACI (n = 108) Control (n = 108) X 2/t P
Age 66.32 ± 11.51 64.46 ± 12.77 1.12 0.26
Male/female 56/52 62/46 0.67 0.41
Etiological sub-types AT 94 (87.1%)
SAD 9 (8.3%)
CE 5 (4.6%)
Sub-types of infarct size L 25 (23.2%)
M 23 (21.3%)
S 51 (47.2%)
LI 9 (8.3%)
Smoking 57 (52.8%) 49 (45.4%) 1.19 0.28
Drinking 34 (31.5%) 38 (35.2%) 0.33 0.56
Hypertension 39 (36.1%) 26 (%) 3.72 0.05
Atrial fibrillation 14 (13.0%) 8 (7.4%) 1.82 0.18
BMI 22.73 ± 2.74 19.36 ± 2.27 9.84 < 0.001
PT (s) 11.78 ± 1.34 12.09 ± 1.39 1.67 0.10
APTT (s) 27.89 ± 2.95 28.63 ± 3.53 1.67 0.10
TC/ (mmoL/L) 4.83 ± 0.37 3.61 ± 0.43 22.35 < 0.001
TG/ (mmoL/L) 1.82 ± 0.24 0.88 ± 0.33 23.94 < 0.001
LDL (mmoL/L) 3.59 ± 0.90 2.32 ± 0.73 11.39 < 0.001
HDL (mmoL/L) 1.16 ± 0.43 1.21 ± 0.24 1.06 0.29
Lp(a) (mg/mL) 152.34 ± 36.47 142.29 ± 39.52 1.94 0.05
Hcy (mmoL/L) 14.43 ± 5.43 11.14 ± 3.78 5.17 < 0.001